Evaluation of Potential Occupational Exposures to Opioid Drugs During a Law Enforcement and Emergency Medical Services Response
The now well-known increase in the illegal distribution and use of fentanyl, fentanyl analogs, and other opioid drugs has led to a greatly heightened risk of opioid exposure for emergency response personnel. NIOSH’s Health Hazard Evaluation Program (HHEP), which investigates potential and known workplace hazards to aid in preventing occupational disease or injury, recently received a request to evaluate one such incident. HHEP findings were published on April 20, 2018 in the above Interim Report. (To view a summary of this report, view the following NES blog: Opioid Exposure Endangering Emergency Responders.)

CDC/NIOSH Fentanyl Safety Webpage
This CDC/NIOSH webpage provides an assembly of resources from the White House, CDC, NIOSH, and elsewhere for use by first responders in staying protected from exposure to fentanyl and other hazardous opioids.

Fentanyl Safety Recommendations for First Responders:
The increased prevalence of fentanyl and other synthetic opioids in the illicit drug market means that first responders need to understand how to protect themselves from exposure in the field. Law enforcement, fire, rescue, and emergency medical services (EMS) personnel must balance safety with mobility and efficiency when responding to scenes where the presence of fentanyl is suspected.

Schedules of Controlled Substances:
DEA places Fentanyl related substances that are not currently listed in the controlled Substance Act are now scheduled as a schedule 1 controlled substance.

Fentanyl: Preventing Occupational Exposure to Emergency Responders:
NIOSH recommendations for protecting emergency responders to fentanyl exposure.

What EMS Providers Need to Know to Protect Themselves from Fentanyl Exposure:
The opioid crisis is better understood as a fentanyl crisis with real dangers to emergency responders, according to an expert-panel presentation convened in Las Vegas at EMS World Expo 2017.

CDC study of Deaths by Fentanyl, Fentanyl Analogs, and U-47700:
This is the first report using toxicologic and death scene evidence across multiple states to characterize opioid overdose deaths.

Disclaimer: NES, Inc. is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use, reference to, or reliance on any information contained within the site. While the information contained within the site is periodically updated, no guarantee is given that the information provided in this Web site is correct, complete, and up-to-date.

Although the NES, Inc. Web site may include links providing direct access to other Internet resources, including Web sites, NES, Inc. is not responsible for the accuracy or content of information contained in these sites.